Showing results (181-190 of 672) with videos related to

Sort By:
Pageof 68
Current Opinion in Infectious Diseases|October 16, 2020
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?Matteo Bassetti, Daniele R Giacobbe, Chiara Robba, et al.
Current Opinion in Infectious Diseases|October 3, 2020
The role of new antimicrobials for Gram-negative infections in daily clinical practiceMatteo Bassetti, Antonio Vena, Denise Battaglini, et al.
Antibiotics (Basel, Switzerland)|September 25, 2020
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat ResistanceMatteo Bassetti, Antonio Vena, Chiara Sepulcri, et al.
Current Opinion in Infectious Diseases|January 26, 2024
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patientsNadia Castaldo, Antonio Vena, Alessandro Limongelli, et al.
Current Opinion in Infectious Diseases|February 7, 2022
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?Matteo Bassetti, Laura Magnasco, Antonio Vena, et al.
Current Opinion in Infectious Diseases|September 28, 2021
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infectionsMatteo Bassetti, Daniele Roberto Giacobbe, Nadia Castaldo, et al.
Expert Review of Anti-Infective Therapy|February 17, 2021
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteriaAlessandro Russo, Marco Berruti, Daniele Roberto Giacobbe, et al.
Current Opinion in Infectious Diseases|January 9, 2025
Omadacycline for the treatment of skin and soft tissue infectionsAntonio Vena, Nadia Castaldo, Daniele Roberto Giacobbe, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 21, 2022
New antibiotics for Gram-negative pneumoniaMatteo Bassetti, Federica Magnè, Daniele Roberto Giacobbe, et al.
Pageof 68